Skip to main content
European Commission logo print header

One-of-a-kind therapy for crossed eyes. Helping families to reduce emotional and financial burden of eye therapy.

Periodic Reporting for period 2 - PLUTO (One-of-a-kind therapy for crossed eyes. Helping families to reduce emotional and financial burden of eye therapy.)

Reporting period: 2020-11-01 to 2021-10-31

The mother of the invention of the RemmedVR system is the need for a large scale - amblyopia and strabismus is one of the most common disorders of binocular vision. They affect up to 5% of children between the ages of 4-12 and disrupt depth perception, hamper motor control, which can lead to injuries. As a result of these disorders, children have impaired visual-motor coordination.
The therapy used so far is long-lasting and requires the involvement of a number of specialists, carers, and frequent visits to doctors' surgeries, and its success requires many patiently performed and burdensome recommendations. The RemmedVR system allows to avoid these tedious and not always effective treatments by introducing the therapy to the virtual reality, which reproduces the exercises performed so far analogically in the offices. RemmedVR is a set that includes VR goggles, mobile motion controllers, an application with exercises in the form of games, a panel for a specialist, and a panel for a parent. It allows the child to exercise their eyesight through play, in a friendly environment, without unnecessary stress under the constant control of a specialist. The subject of the project is both the device and its software. It was created with the participation of ophthalmologists, optometrists, and orthoptists, with the support of renowned medical institutes in Poland and Europe. Already today, thanks to the RemmedVR solution, eye therapists provide services in the form of telemedicine and serve much more patients remotely than in a stationary facility, which is of enormous importance in times of pandemic. Home therapy is more engaging for younger patients and less absorbing for specialists. In addition, the clinics using our system do not incur investment costs for the purchase of expensive equipment, because an innovative model of selling the entire solution in the form of service was applied.
During the second reporting period, the development of additional sensors for head tracking (body tracking) was completed. A number of VR therapy games with compatibility to the additional head and hand motion sensors were designed and developed. The games use the operation of the additional sensors to develop the functionality of head-hand-eye coordination. The therapeutic ranges addressed in therapy on standard analogy devices were specified.
The next phase focused on creating a custom, innovative VR goggle.
The development of our own VR hardware gives us full control over the entire device, both in the development process, medical research and commercialization, and allows us to fully customize the device for the needs of the market.

The initial phase of the clinical validation focused on executing a plan to mitigate the risks associated with conducting a clinical trial. The means to achieve this goal is the scientifc research strategy we have been pursuing. Key hypotheses related to clinical efficacy were confirmed during preliminary studies. The process also allowed us to update the software and hardware according to the feedback collected from the research group. Moreover, a group of 75 patients was recruited.

A revenue plan prepared in an earlier phase of the project was implemented, including a baseline scenario for home and office VR therapy. RemmedVR conducted an extensive market analysis, which provided detailed insight into current business challenges, as well as extensive competitive analysis. The extensive market analysis showed that the best way to meet the sales targets is to work with private eye clinics. Such an assumption favors faster implementation of the RemmedVr solution increasing the effectiveness of selling the service to B2C customers.
RemmedVR continues to work on business development in Europe and the United States with key opinion leaders and clinics. As far as European market development is concerned we are expanding our network by adding operations in Czech Republic and Slovakia. Additionally, a non-provisional patent applications focused on eye tracking technology developed during the project was published.
We managed to reach out and build a lasting relationship with both partners and end customers (patients), using tools such as offline and online campaigns, website, blogs, forums, scientific publications, press releases in trade media, social media (LinkedIn, Instagram, Facebook). The lifting of restrictions related to the COVID-19 pandemic allowed us to attend conferences, including the College of Optometrists in Vision Development and the South-eastern Congress of Optometry and Epomec expanding vision and American Academy of Optometry to show case our solution and accelerate creation of leads.
RemmedVR expanded the "blog" section of the product's website, with patient success stories during and after RemmedVr therapy. We have a consistent presence on social media, raising brand awareness and creating educational content for our clients.
Vision therapy for people with vision disorders and strabismus is most effective when applied at an early age. This is why people who are just a few years old are forced to perform tedious exercises in stationery offices, requiring a high frequency of visits, even up to 3 weeks, absorbing a lot of time for both child and parent. In addition, many children are told to wear eye patches, very uncomfortable for children, and as a result, they have a negative impact on their socializing.
In addition, in times of pandemic, such frequent in-patient visits to doctor's offices are impossible for many families, which clearly results in the complete suspension of therapy for a longer period. As a result, the duration of therapy is significantly increased and its effectiveness is reduced, as therapeutic exercises should be performed regularly and under the supervision of a specialist. There is currently no other available solution that offers an easy-to-use remote for vision problems that are fully monitored by a doctor. This is why our technology is a breakthrough. It combines all scientifically supported therapeutic exercises that have been performed in doctors' offices so far with virtual reality. It is a child-friendly environment, where the therapy takes place by playing simple games. Thanks to an additional system, everything can be done remotely at home, still under the supervision of a specialist. It has its own panel in which it can change the game settings for a given patient's vision disorder and also monitor his progress. Such a solution significantly shortens the duration of therapy, has a positive social impact, can take place both in the doctor's office and at home, increases efficiency by greater involvement of patients in performing the exercises, and many more.
RemmedVR team at the public event
One of our patients using the RemmedVR therapy
Remmed team testing a range of portable VR goggles solutions to find the optimal specification.
RemmedVR team
Remmed team working on creating and testing therapeutic games in VR
Training by an optometrist
Patient playing with therapeutic games using Remmed's headset
Remmed team working on the project